cyclophosphamide [clinicaltrials_resource:3ed5f802cff4f8d396e0df2c42e39f98]
intervention [clinicaltrials_vocabulary:intervention]
cyclophosphamide [clinicaltrials_resource:3ed5f802cff4f8d396e0df2c42e39f98]
Bio2RDF identifier
3ed5f802cff4f8d396e0df2c42e39f98
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3ed5f802cff4f8d396e0df2c42e39f98
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
cyclophosphamide 600 mg/m2 i.v. day 1) every 21 days
intervention name [clinicaltrials_vocabulary:intervention-name]
cyclophosphamide
identifier
clinicaltrials_resource:3ed5f802cff4f8d396e0df2c42e39f98
title
cyclophosphamide
@en
type
label
cyclophosphamide [clinicaltrials_resource:3ed5f802cff4f8d396e0df2c42e39f98]
@en